Next Article in Journal / Special Issue
Carotenoids and Dermoaesthetic Benefits: Public Health Implications
Previous Article in Journal
The Method of Studying Cosmetic Creams Based on the Principles of Systems Theory and Mathematical Modeling Techniques
Previous Article in Special Issue
Filler Migration after Facial Injection—A Narrative Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cosmetics
Volume 10
Issue 5
10.3390/cosmetics10050119
cosmetics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us?

by
Ante Sucic
1,
Ana Seselja Perisin
2,*,
Tomislav Zuvela
2,
Dario Leskur
2,
Doris Rusic
2,
Darko Modun
2 and
Josipa Bukic
2
1
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Split, 21000 Split, Croatia
2
Department of Pharmacy, University of Split School of Medicine, 21000 Split, Croatia
*
Author to whom correspondence should be addressed.
Cosmetics 2023, 10(5), 119; https://doi.org/10.3390/cosmetics10050119
Submission received: 1 August 2023 / Revised: 20 August 2023 / Accepted: 21 August 2023 / Published: 23 August 2023
(This article belongs to the Special Issue Feature Papers in Cosmetics in 2023)
Browse Figure
Review Reports Versions Notes

Abstract

Botulinum toxin use has become the most commonly performed aesthetic procedure among individuals of all age groups, encompassing both women and men. Randomized controlled trials (RCTs) provide the highest level of evidence and quality reporting of their abstracts plays a significant role for health professionals, influencing their decision-making in patient management. Therefore, our study aimed to assess the reporting quality of published RCT abstracts for botulinum toxin aesthetic use in the head area. The CONSORT-A checklist with 17 items was used to assess the quality of reporting. All available RCT abstracts (N = 191) found by searching the Medline database that were published up until June 2023 were included in this study. The average reporting rate was 52.9%. General items were inadequately reported (30.9%), with few abstracts describing the trial design. The methods section was better reported (62.0%), with interventions, objectives, and outcomes properly reported in over 97.5% abstracts. The results section (56.9%) demonstrated good reporting of randomized participant numbers but limited reporting of primary outcomes and harms. None of the abstracts reported funding sources or randomization information. To enhance the transparency and reliability of RCT results, abstracts should adhere more rigorously to the CONSORT-A guidelines. Improved reporting in abstracts can facilitate evidence-based decision-making in everyday practice of medical professionals in the field of aesthetic medicine.
Keywords: botulinum toxin; botox; cosmetic minimally invasive procedures; aesthetic procedures; randomized controlled trials; reporting quality; CONSORT botulinum toxin; botox; cosmetic minimally invasive procedures; aesthetic procedures; randomized controlled trials; reporting quality; CONSORT

Share and Cite

MDPI and ACS Style

Sucic, A.; Perisin, A.S.; Zuvela, T.; Leskur, D.; Rusic, D.; Modun, D.; Bukic, J. Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us? Cosmetics 2023, 10, 119. https://doi.org/10.3390/cosmetics10050119

AMA Style

Sucic A, Perisin AS, Zuvela T, Leskur D, Rusic D, Modun D, Bukic J. Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us? Cosmetics. 2023; 10(5):119. https://doi.org/10.3390/cosmetics10050119

Chicago/Turabian Style

Sucic, Ante, Ana Seselja Perisin, Tomislav Zuvela, Dario Leskur, Doris Rusic, Darko Modun, and Josipa Bukic. 2023. "Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us?" Cosmetics 10, no. 5: 119. https://doi.org/10.3390/cosmetics10050119

APA Style

Sucic, A., Perisin, A. S., Zuvela, T., Leskur, D., Rusic, D., Modun, D., & Bukic, J. (2023). Reporting Quality of Randomized Controlled Trial Abstracts on Aesthetic Use of Botulinum Toxin: How Much Do Abstracts Actually Tell Us? Cosmetics, 10(5), 119. https://doi.org/10.3390/cosmetics10050119

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop